StocksBlueprint Medicines CorpBPMC

BPMC

Blueprint Medicines Corp

95.20 -0.75 (-0.78%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
95.09
B
95.39

Blueprint Medicines Corp

Blueprint Medicines was founded in 2011 and is headquartered in Cambridge, Massachusetts. This precision therapy company is focused on genomically defined cancers, rare diseases and cancer immunotherapy. It develops medicines based on protein kinases, which are enzymes that modify the functions of proteins... Show More
Last Month
2,799
Followers
0.02%
Investors
100% Of them have BUY positions.
A decrease of -0.83% from last trading Day

Related Markets

L3Harris
LHX
-0.04 (-0.02%)
S
210.47
B
211.01
Rathbone Brothers PLC
RAT.L
-23.98 (-1.31%)
S
1806.37
B
1813.63
Encompass Health Corp
EHC
2.27 (2.75%)
S
84.82
B
85.10
Grafton Group PLC
GFTU.L
-8.99 (-0.82%)
S
1088.02
B
1090.98
China Maple Leaf Educational Systems Ltd
1317.HK
-0.020 (-0.99%)
S
2.008
B
2.022
View More
Top
VolatilityAlerts
$BPMC (Blueprint Medicines Corp) shares up over 5.5%
BPMC
Blueprint Medicines Corp
95.09
-0.75 (-0.78%)
Trade
VolatilityAlerts
$BPMC (Blueprint Medicines Corp) falls 5.3% so far. Will it keep dropping?
BPMC
Blueprint Medicines Corp
95.09
-0.75 (-0.78%)
Trade
Like CommentShare
null
.
Coloneltreize